Nicole Germino's Stock Ratings

Truist Securities Analyst

Nicole Germino is an analyst at Truist Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/02/2025

Overall Average Return

-2.09%

Smart Score

43.3%

Overall Average Return Percentile

35th

Number of Ratings

28
Buy NowGet Alert
04/07/2025CATXBuy Now
Perspective Therapeutics
——
Nicole Germino43%
$21 → $10MaintainsBuyGet Alert
03/05/2025YMABBuy Now
Y-mAbs Therapeutics
$4.11337.96%
Nicole Germino43%
$21 → $18MaintainsBuyGet Alert
02/21/2025INSMBuy Now
Insmed
$72.6448.68%
Nicole Germino43%
$105 → $108MaintainsBuyGet Alert
01/23/2025SGMOBuy Now
Sangamo Therapeutics
$0.76554.45%
Nicole Germino43%
$7 → $5MaintainsBuyGet Alert
11/01/2024INSMBuy Now
Insmed
$72.6444.55%
Nicole Germino43%
$100 → $105ReiteratesBuy → BuyGet Alert
10/11/2024INSMBuy Now
Insmed
$72.6437.67%
Nicole Germino43%
$85 → $100MaintainsBuyGet Alert
09/25/2024CATXBuy Now
Perspective Therapeutics
——
Nicole Germino43%
→ $21Initiates → BuyGet Alert
08/12/2024INSMBuy Now
Insmed
$72.6417.02%
Nicole Germino43%
$88 → $85MaintainsBuyGet Alert
07/01/2024INSMBuy Now
Insmed
$72.6421.15%
Nicole Germino43%
$68 → $88MaintainsBuyGet Alert
06/28/2024YMABBuy Now
Y-mAbs Therapeutics
$4.11410.95%
Nicole Germino43%
→ $21Initiates → BuyGet Alert
05/29/2024INSMBuy Now
Insmed
$72.64-6.39%
Nicole Germino43%
$48 → $68MaintainsBuyGet Alert
05/16/2024INSMBuy Now
Insmed
$72.64-33.92%
Nicole Germino43%
$48 → $48MaintainsBuyGet Alert
04/23/2024INSMBuy Now
Insmed
$72.64-33.92%
Nicole Germino43%
→ $48Initiates → BuyGet Alert
03/20/2024FUSNBuy Now
Fusion Pharmaceuticals
——
Nicole Germino43%
$11 → $21DowngradeBuy → HoldGet Alert
03/19/2024FUSNBuy Now
Fusion Pharmaceuticals
——
Nicole Germino43%
$11 → $21DowngradeBuy → HoldGet Alert
11/07/2023SGMOBuy Now
Sangamo Therapeutics
$0.76—
Nicole Germino43%
—DowngradeBuy → HoldGet Alert
10/04/2023PNTBuy Now
POINT Biopharma Global
——
Nicole Germino43%
$13 → $12.5DowngradeBuy → HoldGet Alert
08/15/2023SGMOBuy Now
Sangamo Therapeutics
$0.76816.23%
Nicole Germino43%
$8 → $7MaintainsBuyGet Alert
05/10/2023SGMOBuy Now
Sangamo Therapeutics
$0.76947.12%
Nicole Germino43%
$16 → $8MaintainsBuyGet Alert
11/15/2022PNTBuy Now
POINT Biopharma Global
——
Nicole Germino43%
$22 → $14MaintainsBuyGet Alert
10/24/2022ASMBBuy Now
Assembly Biosciences
$9.80-79.59%
Nicole Germino43%
$132 → $24DowngradeBuy → HoldGet Alert
09/16/2022FUSNBuy Now
Fusion Pharmaceuticals
——
Nicole Germino43%
→ $10Initiates → BuyGet Alert
09/16/2022PNTBuy Now
POINT Biopharma Global
——
Nicole Germino43%
→ $22Initiates → BuyGet Alert
04/05/2022SGMOBuy Now
Sangamo Therapeutics
$0.762386.91%
Nicole Germino43%
$23 → $19MaintainsBuyGet Alert
04/01/2022ASMBBuy Now
Assembly Biosciences
$9.8022.45%
Nicole Germino43%
$180 → $144MaintainsBuyGet Alert
09/03/2021FBRXBuy Now
Forte Biosciences
$7.30—
Nicole Germino43%
—DowngradeBuy → HoldGet Alert
10/19/2020ASMBBuy Now
Assembly Biosciences
$9.80461.22%
Nicole Germino43%
→ $660Initiates → BuyGet Alert
08/25/2020FBRXBuy Now
Forte Biosciences
$7.30858.9%
Nicole Germino43%
→ $1750Initiates → BuyGet Alert